During Friday’s Current trade, Shares of Robert Half International Inc. (NYSE:RHI), lost -0.12% to $51.20.
The 2016 Salary Guides from Robert Half reveal U.S. starting salaries for professional occupations are predictable to enhance an average of 4.1 percent next year. Among the five fields tracked, the technology sector is projected to see the greatest pay gains, with base salaries rising an average of 5.3 percent. Accounting and finance roles followed, with anticipated average compensation enhances of 4.7 percent. The creative and administrative professions each registered projected starting salary gains of 3.8 percent, followed by the legal field, with average base pay predictable to rise 3.1 percent in 2016.
When it comes to keeping the best and brightest, benchmarking compensation is essential, suggests research from Robert Half. Among more than 1,000 professionals polled, 83 percent said a bigger salary would be a top factor prompting them to move to another company. The research also revealed that it would take a 26 percent salary enhance, on average, to compel employees to head for greener pastures.
Robert Half International Inc. provides staffing and risk consulting services in North America, South America, Europe, Asia, and Australia. It operates through three segments: Temporary and Consultant Staffing, Permanent Placement Staffing, and Risk Consulting and Internal Audit Services. The company places temporary and full-time office and administrative personnel ranging from executive and administrative assistants, receptionists, and customer service representatives; full-time accounting, financial, tax, and accounting operations personnel; full-time employees in the areas ranging from multiple platform systems integration to end-user support, counting specialists in Web development, networking, application development, systems integration, database design, security and business continuity, and desktop support; and temporary and full-time employees in attorney, paralegal, legal administrative, and legal secretarial positions.
Shares of UGI Corp (NYSE:UGI), inclined 0.38% to $33.32, during its current trading session.
PennEast Pipeline Company LLC (PennEast) declared awards of $50,000 through its Community Connector Grant Program, bringing the program’s investment in Pennsylvania and New Jersey communities to $240,000 to date.
Projects benefitting from the Community Connector Program comprise: a rain garden for sedimentation control; funding for environmental educational programs; and hydraulic rescue equipment, to name a few. The following area not-for-profit organizations have been selected to receive the grants:
- Carbon County Environmental Center.
- Dimmick Memorial Library (Jim Thorpe, PA).
- Franklin Township Volunteer Fire Company (Lehighton, Pa.).
- Lehigh Township Emergency Administration.
- Lehigh Township Volunteer Fire Company #1.
- Lehighton Shade Tree Commission.
- Penn Kidder Library Center.
UGI Corporation, through its auxiliaries, distributes, stores, transports, and markets energy products and related services in the United States and internationally. It distributes propane to about 2 million residential, commercial/industrial, motor fuel, agricultural, and wholesale customers in 50 states through 2,500 propane distribution locations; and sells, installs, and services propane appliances, counting heating systems.
Ball Corporation (NYSE:BLL), during its Thursday’s current trading session decreased -0.99% to $66.20.
Ball Corporation has been named the industry leader for container and packaging companies on the 2015 Dow Jones Sustainability Indices (DJSI) for the third successive year. Ball Corporation (BLL) maintained its best-in-class position on both the DJSI World Index, and the Dow Jones Sustainability Index North America (DJSI NA).
“Achieving placement on the prestigious Dow Jones indices for sustainability is noteworthyand we’re proud to be listed once again,” said John A. Hayes, chairman, president and CEO. “At Ball, sustainability is both a core value and a long-term investment. Congratulations to each of our employees around the world who drive Ball’s culture of sustainability and its progress.”
The DJSI World Index tracks the performance of the top 10 percent of the 2,500 largest companies on the S&P Global Broad Market IndexSM that lead the field in terms of sustainability; while the DJSI NA tracks the performance of the top 20 percent of the 600 largest Canadian and United States companies. Ball earned industry-leading scores in the environmental and social dimensions and scored particularly well on criteria integral to its Drive for 10 vision such as operational health and safety, operational eco-efficiency, product stewardship and stakeholder engagement.
Ball Corporation, together with its auxiliaries, supplies metal packaging products to the beverage, food, personal care, and household products industries worldwide. It operates in four segments: Metal Beverage Packaging, Americas and Asia; Metal Beverage Packaging, Europe; Metal Food and Household Products Packaging; and Aerospace and Technologies. The Metal Beverage Packaging, Americas and Asia segment manufactures and sells metal beverage containers for use in beverage packaging.
Finally, ImmunoGen, Inc. (NASDAQ:IMGN), gained 1.06%, to $13.41.
ImmunoGen, Inc. ( IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, recently declared the Company will take part in the Morgan Stanley Global Healthcare Conference. ImmunoGen President and CEO Daniel Junius will talk about the Company in a “fireside chat” moderated question and answer session that will be webcast starting at 2:50 pm ET on September 16, 2015.
ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugates technology. It offers Kadcyla, an antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer. The company’s clinical stage anticancer compounds comprise IMGN853 for the treatment of ovarian cancer, endometrial cancer, and other cancers, in addition to IMGN529 and coltuximab ravtansine for the treatment of diffuse large B-cell lymphoma and other B-cell malignancies; and preclinical stage compounds comprise IMGN779 for the treatment of acute myeloid leukemia and myelodysplastic syndrome.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
